Behnood Bikdeli, MD, MS
@bbikdeli.bsky.social
74 followers 43 following 9 posts
Father, husband, cardiologist 🫀, investigator, #thrombosis, #antithrombotic therapy
Posts Media Videos Starter Packs
Reposted by Behnood Bikdeli, MD, MS
scinews.bsky.social
This Review summarizes the diagnosis and treatment of Superficial vein thrombosis (SuVT).

jamanetwork.com/journals/jam...
Reposted by Behnood Bikdeli, MD, MS
jama.com
JAMA @jama.com · 26d
Superficial vein thrombosis (SuVT) is characterized by thrombus in the superficial veins, typically in the lower or upper extremities.

This Review summarizes the diagnosis and treatment of SuVT.

ja.ma/4mlIxPL
Diagram from JAMA, Sept 15, 2025, titled "Superficial Vein Thrombosis: A Review." It shows common sites and pathophysiology of SuVT in upper and lower extremities, detailing vein names, thrombus formation, inflammation, and impeded blood flow.
bbikdeli.bsky.social
Summary of the guideline recs for #anticoagulant & #antiplatelet therapy in ACS c/w prior recs in @americanheart.bsky.social @accintouch.bsky.social and @escardio.bsky.social guidelines. Thankful to Writing Committee & also a great team who made this summary possible:
www.jacc.org/doi/10.1016/...
bbikdeli.bsky.social
Must do better for #PE risk stratification. In an @escardio.bsky.social
#EHJ paper we show that a multimarker calculator🌡️outperforms the ESC model. Great leadership by
#DavidJimenez @mmonrealriete.bsky.social
#RIETE! 👇:

tinyurl.com/trpmzbrd
Reposted by Behnood Bikdeli, MD, MS
gbarnesmd.bsky.social
I often get asked if it’s safe to use #cvCoag mono therapy in patients with AF and stable CAD (i.e., PCI>6-12 months prior). @bbikdeli.bsky.social clearly shows safety and efficacy with OAC motherly in this population. #ACForum25
Reposted by Behnood Bikdeli, MD, MS
anticoagpharmd.bsky.social
Did you know that NATF has rebranded? Check out the brand new Vasculearn Network: www.google.com/url?q=https:...
Their dynamic site is full of great resources for patients & providers.
I personally love their patient support groups and reading What’s Hot in Clots by @bbikdeli.bsky.social!
Redirecting
www.google.com
Reposted by Behnood Bikdeli, MD, MS
thjournal.bsky.social
📑Navigating Anticoagulation 💊 in Ischemic Left Ventricular Aneurysms: Lessons from Cardiac 🫀MRI

Read Editorial by Ashkan Hashemi and @bbikdeli.bsky.social www.thieme-connect.de/products/ejo...

Original Article 📰 here www.thieme-connect.de/products/ejo...
Reposted by Behnood Bikdeli, MD, MS
bbikdeli.bsky.social
For antithrombotic 💊 in AF+ACS/PCI:
-Many pts have recurrent ischemia or🩸.
-#AUGUSTUS results @dcrinews.bsky.social in @jaccjournals.bsky.social shows:

1.Apixaban ⬇️🩸c/w warfarin w/o ⬆️thrombosis
2. Placebo ⬇️🩸c/w aspirin w/o ⬆️thrombosis
Paper: tinyurl.com/2s4kuy8m
The Editorial: tinyurl.com/4evteweb
Reposted by Behnood Bikdeli, MD, MS
cardioobdoc.bsky.social
Anticoagulation & Antiplatelet Therapy for #AFib & Stable CAD: Meta-analysis of RCTs

Will this finally change the practice?

#CardioSky #MedSky
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @bbikdeli.bsky.social @hmkyale.bsky.social @csilvers.bsky.social @load-dependent.bsky.social
bbikdeli.bsky.social
This is a collaborative meta-analysis of 4 RCTs reporting findings overall and across pre-specified subgroups. In brief, it shows consistent reduction in bleeding with A/C monotherapy but no major increase in ischemic events.

What other colleagues do in routine practice is known from other studies.
bbikdeli.bsky.social
Ummm....One would hope so, but routine practice data from US, Europe and elsewhere show that pts receive dual therapy far too often without strong reasons.
bbikdeli.bsky.social
😂😂Thank you so much @gbarnesmd.bsky.social for ur extremely kind words and for covering our study! Lots of credit to Sina for leading the effort, to the trial PIs who kindly helped w study-level unpublished data for certain outcomes/subgroups, and to team! 👏
gbarnesmd.bsky.social
When does @bbikdeli.bsky.social sleep? I'm not sure - he's constantly publishing highly impactful work!! This week is no different. Check out this important meta-analysis on #cvCoag and #antiplatleet use in #AFib and stable #CAD! Less is more!!! @jaccjournals.bsky.social www.jacc.org/doi/10.1016/...
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-analysis of Randomized Trials:
www.jacc.org
Reposted by Behnood Bikdeli, MD, MS
bbikdeli.bsky.social
When pts have stable #CAD & #AF, do we need both #anticoagulant therapy and #antiplatelet agents? Our collaborative meta-analysis of RCTs shows that monotherapy with anticoagulation ⬇️🩸 without a large increase in ischemic events. @jaccjournals.bsky.social

www.jacc.org/doi/10.1016/...
Reposted by Behnood Bikdeli, MD, MS
hmkyale.bsky.social
Happy holidays from @jaccjournals.bsky.social - we pride ourselves on speed and wisdom in making editorial decisions…and yet, our offices and editors will take a holiday break. We urge everyone to take some time to recharge. See you in 2025! www.youtube.com/watch?v=zYln...
JACC | Happy Holidays
YouTube video by American College of Cardiology
www.youtube.com
bbikdeli.bsky.social
Totally agree. Should have. We may have not covered all points. Appreciate your thoughtful comment, as always!
Reposted by Behnood Bikdeli, MD, MS
thjournal.bsky.social
💊 Direct Oral Anticoagulants: a quick primer on when to use ✅ and when to avoid ❌

Read on TH 👉 www.thieme-connect.com/products/ejo...

#HemSky #CardioSky
Reposted by Behnood Bikdeli, MD, MS
thjournal.bsky.social
📢🆓Effective immediately, Thrombosis and Haemostasis no longer imposes page and color charges for articles published in the journal!

We look forward to your submissions and hope this adjustment will facilitate a smoother publishing process!
Reposted by Behnood Bikdeli, MD, MS
cardioobdoc.bsky.social
Sex differences in treatment strategies for pulmonary embolism in older adults: SERIOUS-PE study of RIETE participants & US Medicare beneficiaries

#CardioSky #MedSky
@bbikdeli.bsky.social @heatherlgornik.bsky.social @hmkyale.bsky.social
journals.sagepub.com/eprint/NPMGB...